Package 11673-181-50

{"route": ["ORAL"], "spl_id": "22771129-deba-e3a1-e063-6394a90a7e92", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0349483481501"], "unii": ["R16CO5Y76E"], "rxcui": ["308416"], "spl_set_id": ["8ed252be-8fdb-3809-e053-2995a90a4b4f"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["TARGET CORPORATION"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (11673-181-12)  / 120 TABLET, COATED in 1 BOTTLE", "package_ndc": "11673-181-12", "marketing_start_date": "20200101"}, {"sample": false, "description": "500 TABLET, COATED in 1 BOTTLE (11673-181-50)", "package_ndc": "11673-181-50", "marketing_start_date": "20200101"}], "brand_name": "ASPIRIN", "product_id": "11673-181_22771129-deba-e3a1-e063-6394a90a7e92", "dosage_form": "TABLET, COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "11673-181", "generic_name": "ASPIRIN", "labeler_name": "TARGET CORPORATION", "product_type": "HUMAN OTC DRUG", "brand_name_base": "ASPIRIN", "active_ingredients": [{"name": "ASPIRIN", "strength": "81 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20200101", "listing_expiration_date": "20261231"}